| - Industry | - Sector | - CEO | KRX SM Exchange | - ISIN |
| KR Country | - Employees | - Last Dividend | 21 Jul 2020 Last Split | - IPO Date |
Founded in 2000 and based in Seoul, South Korea, ProteomeTech Inc. is a biotechnology company engaged in designing, developing, and selling various diagnostic kits. The company focuses on leveraging immunoblotting techniques, total IgG concentration measurements, qualitative human chorionic gonadotropin tests, and other advanced methods for developing its products. ProteomeTech Inc. specializes in creating diagnostic solutions for allergies, food intolerance, pregnancy, and infectious diseases like SARS-CoV-2, catering to both human and veterinary needs. With its commitment to health and wellness, ProteomeTech Inc. aims to provide accurate and reliable diagnostic tools to improve patient care and treatment outcomes.